<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03215420</url>
  </required_header>
  <id_info>
    <org_study_id>DIORFLAR- BOZORG 2016</org_study_id>
    <nct_id>NCT03215420</nct_id>
  </id_info>
  <brief_title>Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease</brief_title>
  <acronym>MRI Meniere</acronym>
  <official_title>Diagnostic Agreement of Electrophysiological Audiovestibular Examinations With Magnetic Resonance Imaging (MRI) of the Inner Ear in Revealing Endolymphatic Hydrops (EH) in Patients With Certain or Probable Meniere's Disease (MD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare 3 methods for the diagnosis of endolymphatic hydrops (EH)
      in patients with Meniere's disease: MRI 3 Tesla (to visualise EH directly), and functional
      explorations, namely electrocochleography and dephasing of acoustic distortion products
      (which are modified by the EH).

      The research hypothesis is that the examinations will show agreement in the diagnosis of EH,
      and that the results obtained (quantitative values) will vary in the same direction over time
      and during flares of MD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2016</start_date>
  <completion_date type="Anticipated">September 8, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients for whom an endolymphatic hydrops was diagnosed by electrocochleography</measure>
    <time_frame>day one</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients for whom an endolymphatic hydrops was diagnosed by (Dephasing) of acoustic distortion products</measure>
    <time_frame>day one</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients for whom an endolymphatic hydrops was diagnosed by 3T MRI 3T</measure>
    <time_frame>day one</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">43</enrollment>
  <condition>Endolymphatic Hydrops</condition>
  <arm_group>
    <arm_group_label>Certain or probable Meniere's disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MRI 3T</intervention_name>
    <arm_group_label>Certain or probable Meniere's disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  persons who have provided written consent

          -  persons aged 18 to 75 years

          -  persons with certain or probable Meniere's disease according to the international
             classification AAO-HNS

        Exclusion Criteria:

          -  persons without health insurance cover

          -  adults under guardianship

          -  persons with a history of hypersensitivity to the active substance or to one of the
             excipients of the contrast agent used for the MRI or to any gadolinium chelate

          -  pregnant or breast-feeding women

          -  severe acute or chronic kidney failure

          -  other identified causes of cochleo-vestibular syndromes

          -  Impossibility to follow-up or carry out any of the examinations necessary for the
             protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexis BOZORG GRAYELI</last_name>
    <phone>3 80 29 37 58</phone>
    <phone_ext>+33</phone_ext>
    <email>alexis.bozorggrayeli@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHu Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexis Bozorg Grayeli</last_name>
      <phone>3 80 29 37 58</phone>
      <phone_ext>+33</phone_ext>
      <email>alexis.bozorggrayeli@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2017</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meniere Disease</mesh_term>
    <mesh_term>Edema</mesh_term>
    <mesh_term>Endolymphatic Hydrops</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

